{
    "clinical_study": {
        "@rank": "158003", 
        "acronym": "HypoANS", 
        "arm_group": [
            {
                "arm_group_label": "Euglycemic clamp plus placebo.", 
                "arm_group_type": "Sham Comparator", 
                "description": "participant undergoes a euglycemic hyperinsulinemic clamp with placebo pretreatment"
            }, 
            {
                "arm_group_label": "hypoglycemic clamp plus placebo", 
                "arm_group_type": "Active Comparator", 
                "description": "participant undergoes a hypoglycemic hyperinsulinemic clamp with placebo pretreatment"
            }, 
            {
                "arm_group_label": "hypoglycemia plus eplerenone", 
                "arm_group_type": "Experimental", 
                "description": "participant undergoes a hypoglycemic hyperinsulinemic clamp with eplerenone pretreatment"
            }
        ], 
        "brief_summary": {
            "textblock": "The goals of this proposal are to determine the effects of hypoglycemia on the autonomic\n      nervous system and whether administration of a mineralocorticoid receptor antagonist\n      modifies the effects of hypoglycemia on the autonomic nervous system"
        }, 
        "brief_title": "Hypoglycemia and Autonomic Nervous System Function", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypoglycemia", 
        "condition_browse": {
            "mesh_term": "Hypoglycemia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy volunteers\n\n          -  Males and females age 18 to 50\n\n          -  Type I Diabetes Mellitus, OR:\n\n          -  Type II Diabetes Mellitus controlled by diet, exercise and oral glycemic control\n             agents (metformin, thiazolidinediones, sulfonylureas)\n\n        Exclusion Criteria:\n\n          -  Hemoglobin A1c > 9% (Type 2 Diabetes mellitus)\n\n          -  Hemoglobin A1c < 8% or > 10% (Type 1 Diabetes mellitus)\n\n          -  Pregnancy\n\n          -  Lactation\n\n          -  Recurrent hypoglycemic episodes within the past month\n\n          -  Subjects who smoke will be required to refrain from smoking for the duration of each\n             study admission\n\n          -  Clinically significant coronary artery, cerebrovascular, or peripheral vascular\n             disease, or presence of systemic illness that might affect autonomic function. Such\n             illnesses include diabetes mellitus (controls only) congestive heart failure,\n             hypertension (controls only), renal, pulmonary, hepatic disease, anemia,\n             malignancies, untreated thyroid disease, and alchoholism.\n\n          -  Current major depressive illness\n\n          -  In both controls and diabetic subjects, any individuals on oral, injected, inhaled or\n             topical corticosteroids within the last year or oral contraceptives within the past 3\n             months will be excluded.\n\n          -  Use of medications other than thyroxine in control subjects\n\n          -  Use of medications other than thyroxine, metformin, thiazolidinediones,\n             sulfonylureas, statins, ACE inhibitors, angiotensin receptor blockers (ARBs), and\n             hydrochlorothiazide (HCTZ) in diabetic subjects\n\n          -  Blood pressure > 140/90 mmHg.\n\n          -  Creatinine > 1.5 mg/dL\n\n          -  Serum potassium >5.2 mmol/L\n\n          -  Estimated GFR < 50 mL/min"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "260", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01816893", 
            "org_study_id": "2004P001233"
        }, 
        "intervention": [
            {
                "arm_group_label": "hypoglycemia plus eplerenone", 
                "intervention_name": "Eplerenone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Euglycemic clamp plus placebo.", 
                    "hypoglycemic clamp plus placebo"
                ], 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Hypoglycemic Agents", 
                "Eplerenone"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hypoglycemia", 
            "Autonomic Nervous System"
        ], 
        "lastchanged_date": "March 20, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Maria Baimas-George"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Brigham and Women's Hospital"
                }, 
                "investigator": {
                    "last_name": "Gail K Adler, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Sarah Ballatori"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Beth Israel Deaconess Medical Center"
                }, 
                "investigator": {
                    "last_name": "Roy Freeman, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Hypoglycemia and Autonomic Nervous System Function", 
        "overall_contact": {
            "email": "mbaimas-george@partners.org", 
            "last_name": "Maria Baimas-George, BA", 
            "phone": "617-525-7357"
        }, 
        "overall_contact_backup": {
            "email": "sballato@bidmc.harvard.edu", 
            "last_name": "Sarah Ballatori, BA", 
            "phone": "617-632-0648"
        }, 
        "overall_official": [
            {
                "affiliation": "Brigham and Women's Hospital", 
                "last_name": "Gail K Adler, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Beth Israel Deaconess Medical Center", 
                "last_name": "Roy L Freeman, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Modified Oxford method assessment of baroreflex function", 
                "safety_issue": "No", 
                "time_frame": "1 day after euglycemic and hypoglycemic clamps"
            }, 
            {
                "measure": "Muscle sympathetic nerve activity", 
                "safety_issue": "No", 
                "time_frame": "1 day after euglycemic and hypoglycemic clamps"
            }, 
            {
                "measure": "Catecholamine response to lower-body negative pressure", 
                "safety_issue": "No", 
                "time_frame": "1 day after euglycemic and hypoglycemic clamps"
            }, 
            {
                "measure": "Modified Oxford method assessment of baroreflex function", 
                "safety_issue": "No", 
                "time_frame": "during euglycemic and hypoglycemic clamps"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01816893"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Brigham and Women's Hospital", 
            "investigator_full_name": "Gail Adler", 
            "investigator_title": "Associate Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": [
            {
                "PMID": "18332163", 
                "citation": "Dotson S, Freeman R, Failing HJ, Adler GK. Hypoglycemia increases serum interleukin-6 levels in healthy men and women. Diabetes Care. 2008 Jun;31(6):1222-3. doi: 10.2337/dc07-2243. Epub 2008 Mar 10."
            }, 
            {
                "PMID": "19056608", 
                "citation": "Adler GK, Bonyhay I, Failing H, Waring E, Dotson S, Freeman R. Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes. 2009 Feb;58(2):360-6. doi: 10.2337/db08-1153. Epub 2008 Dec 3."
            }, 
            {
                "PMID": "22921261", 
                "citation": "Gibbons CH, Adler GK, Bonyhay I, Freeman R. Experimental hypoglycemia is a human model of stress-induced hyperalgesia. Pain. 2012 Nov;153(11):2204-9. doi: 10.1016/j.pain.2012.06.030. Epub 2012 Aug 23."
            }
        ], 
        "source": "Brigham and Women's Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Beth Israel Deaconess Medical Center", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Brigham and Women's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2005", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}